Anti-human RTN4 / NOGO (Atinumab Biosimilar) Size:20 mg PSA-NCAM expression is prevalent during

PSA-NCAM expression is prevalent during development of the brain

Antibodies to GFAP are very useful as markers of astrocytic cells

Target Name CSF2 / GM-CSF Target Uniprot P04141 Overview

Furthermore

zgc:110058

Anti-human RTN4 / NOGO (Atinumab Biosimilar) Size:20 mg PSA-NCAM expression is prevalent duringApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name RTN4 NOGO Target Uniprot Q9NQC3 Overview Catalog# BIO0759SM Product Name Anti human RTN4 NOGO (Atinumab Biosimilar) Specifications Conjugation None Clone# Atinumab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O Concentration